Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹4.25, the stock trades at a trailing P/E ratio of 29.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 81% over the past three years. Ankündigung • Mar 13
Kamdhenu Ventures Limited announced a financing transaction Kamdhenu Ventures Limited announced a private placement of Pre-Funded Convertible Warrants of the company on March 13, 2026. The Warrants are convertible into Common Shares of the company on preferential basis. The transaction has been approved in the Extra Ordinary General Meeting of the Company. Reported Earnings • Feb 14
Third quarter 2026 earnings released: EPS: ₹0.03 (vs ₹0.063 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.03 (down from ₹0.063 in 3Q 2025). Revenue: ₹633.5m (down 14% from 3Q 2025). Net income: ₹9.91m (down 50% from 3Q 2025). Profit margin: 1.6% (down from 2.7% in 3Q 2025). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Ankündigung • Feb 12
Kamdhenu Ventures Limited announced that it expects to receive INR 50.3965 million in funding from Kamdhenu Limited Kamdhenu Ventures Limited announced a private placement to issue 29,645,000 convertible warrants at an issue price of INR 1.7 for the proceeds of INR 50,396,500 on February 12, 2026. The transaction involves participation from Kamdhenu Limited for 29,645,000 shares for 8.62% stake. The Transaction is approved by board of directors and is subject to approval of shareholders and applicable regulatory authorities. The warrants will be convertible into one common share of the company at INR 5.1 per share and will mature in 18 months from the date of the allotment. The securities will be issued on preferential basis. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹7.25, the stock trades at a trailing P/E ratio of 39.6x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 62% over the past year. Reported Earnings • Nov 12
Second quarter 2026 earnings released: EPS: ₹0.032 (vs ₹0.038 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.032 (down from ₹0.038 in 2Q 2025). Revenue: ₹569.1m (up 3.8% from 2Q 2025). Net income: ₹10.1m (down 15% from 2Q 2025). Profit margin: 1.8% (down from 2.2% in 2Q 2025). The decrease in margin was driven by higher expenses. Ankündigung • Aug 28
Kamdhenu Ventures Limited, Annual General Meeting, Sep 26, 2025 Kamdhenu Ventures Limited, Annual General Meeting, Sep 26, 2025, at 15:00 Indian Standard Time. Reported Earnings • Aug 15
First quarter 2026 earnings released: EPS: ₹0.028 (vs ₹0.051 in 1Q 2025) First quarter 2026 results: EPS: ₹0.028 (down from ₹0.051 in 1Q 2025). Revenue: ₹503.5m (down 7.5% from 1Q 2025). Net income: ₹8.73m (down 45% from 1Q 2025). Profit margin: 1.7% (down from 2.9% in 1Q 2025). The decrease in margin was driven by lower revenue. Ankündigung • Aug 02
Kamdhenu Ventures Limited to Report Q1, 2026 Results on Aug 14, 2025 Kamdhenu Ventures Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Independent & Non-Executive Director Ramesh Surana was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Jun 13
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 400% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (400% increase in shares outstanding). Minor Risks Profit margins are more than 30% lower than last year (2.5% net profit margin). Market cap is less than US$100m (₹3.68b market cap, or US$42.7m). Reported Earnings • May 10
Full year 2025 earnings released: EPS: ₹0.21 (vs ₹0.44 in FY 2024) Full year 2025 results: EPS: ₹0.21 (down from ₹0.44 in FY 2024). Revenue: ₹2.67b (down 8.6% from FY 2024). Net income: ₹66.6m (down 52% from FY 2024). Profit margin: 2.5% (down from 4.7% in FY 2024). The decrease in margin was driven by lower revenue. Ankündigung • May 01
Kamdhenu Ventures Limited to Report Q4, 2025 Results on May 08, 2025 Kamdhenu Ventures Limited announced that they will report Q4, 2025 results at 12:08 PM, Indian Standard Time on May 08, 2025 Valuation Update With 7 Day Price Move • Apr 23
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹11.63, the stock trades at a trailing P/E ratio of 40.8x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 68% over the past year. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹12.20, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 68% over the past year. Ankündigung • Feb 28
Kamdhenu Ventures Limited Appoints Mr. Nikhil Sukhija as Company Secretary and Compliance Officer Kamdhenu Ventures Limited the Board of Directors of the Company at their meeting held on, 28 February, 2025, has appointed Mr. Nikhil Sukhija, a qualified Company Secretary having ICSI M. No: 66209, as the Company Secretary & Compliance Officer and also designated as Key Managerial Personnel of the Company with effect from 28 February, 2025. CS Nikhil Sukhija is an experienced professional with 5 years of expertise in Corporate Secretarial and Compliance functions. He is a Qualified Company Secretary and an Associate Member of the Institute of Company Secretaries of India ("ICSI"). Additionally, he also holds a degree of Bachelor of Commerce and also a Law Graduate. CS Nikhil Sukhija s a seasoned corporate professional with a distinguished career at reputed Listed Companies as well as big Corporates. He has been associated with the Kamdhenu Group since last one year and managing the Compliances under Corporate Laws, SEBI Listing Regulations, SEBI Insider Trading Regulation, other regular compliances and ancillary Compliances etc. His expertise spans he Companies Act, SEBI regulations, Secretarial Audits, Private Placements, Right Issue and Legal Compliances, showcasing his ability to navigate complex regulatory landscapes and drive sustainable corporate practices. Reported Earnings • Feb 15
Third quarter 2025 earnings released: EPS: ₹0.063 (vs ₹0.13 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.063 (down from ₹0.13 in 3Q 2024). Revenue: ₹742.0m (down 6.2% from 3Q 2024). Net income: ₹19.9m (down 51% from 3Q 2024). Profit margin: 2.7% (down from 5.2% in 3Q 2024). The decrease in margin was driven by lower revenue. Ankündigung • Feb 05
Kamdhenu Ventures Limited to Report Q3, 2025 Results on Feb 13, 2025 Kamdhenu Ventures Limited announced that they will report Q3, 2025 results on Feb 13, 2025 Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₹20.55, the stock trades at a trailing P/E ratio of 58.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total loss to shareholders of 34% over the past year. Ankündigung • Nov 30
Kamdhenu Ventures Limited and Kamdhenu Colour and Coatings Limited Announce Resignation of Nitin Misra as Company Secretary & Compliance Officer, Effective 30 November 2024 Kamdhenu Ventures Limited announced that, Shri Nitin Misra, company secretary & compliance officer of the company, has tendered his resignation from the post of company secretary & compliance officer (Key Managerial Personnel) of the company and also from the post of Company Secretary (Key Managerial Personnel) of Kamdhenu Colour and Coatings Limited, with effect from the closure of business hours on 30 November 2024, to pursue career opportunities outside the organization. Reported Earnings • Nov 12
Second quarter 2025 earnings released: EPS: ₹0.038 (vs ₹0.11 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.038 (down from ₹0.11 in 2Q 2024). Revenue: ₹549.8m (down 17% from 2Q 2024). Net income: ₹11.9m (down 65% from 2Q 2024). Profit margin: 2.2% (down from 5.2% in 2Q 2024). The decrease in margin was driven by lower revenue. Ankündigung • Nov 05
Kamdhenu Ventures Limited to Report Q2, 2025 Results on Nov 11, 2024 Kamdhenu Ventures Limited announced that they will report Q2, 2025 results on Nov 11, 2024 Valuation Update With 7 Day Price Move • Oct 24
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹20.59, the stock trades at a trailing P/E ratio of 49.1x. Average trailing P/E is 34x in the Chemicals industry in India. Total loss to shareholders of 28% over the past year. New Risk • Oct 08
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₹8.12b (US$96.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Significant insider selling over the past 3 months (₹15m sold). Market cap is less than US$100m (₹8.12b market cap, or US$96.8m). Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment deteriorates as stock falls 41% After last week's 41% share price decline to ₹33.59, the stock trades at a trailing P/E ratio of 79.5x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 5.7% over the past year. Ankündigung • Jul 31
Kamdhenu Ventures Limited to Report Q1, 2025 Results on Aug 10, 2024 Kamdhenu Ventures Limited announced that they will report Q1, 2025 results on Aug 10, 2024 New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Significant insider selling over the past 3 months (₹6.8m sold). Reported Earnings • Jul 21
Full year 2024 earnings released: EPS: ₹0.44 (vs ₹0.54 loss in FY 2023) Full year 2024 results: EPS: ₹0.44 (up from ₹0.54 loss in FY 2023). Revenue: ₹2.92b (up 12% from FY 2023). Net income: ₹138.5m (up ₹251.2m from FY 2023). Profit margin: 4.7% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Ankündigung • Jul 09
Kamdhenu Ventures Limited, Annual General Meeting, Aug 07, 2024 Kamdhenu Ventures Limited, Annual General Meeting, Aug 07, 2024, at 16:00 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to ₹40.85, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 93% over the past year. Reported Earnings • May 08
Full year 2024 earnings released: EPS: ₹2.21 (vs ₹3.74 loss in FY 2023) Full year 2024 results: EPS: ₹2.21 (up from ₹3.74 loss in FY 2023). Revenue: ₹2.93b (up 13% from FY 2023). Net income: ₹138.5m (up ₹251.2m from FY 2023). Profit margin: 4.7% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. New Risk • Mar 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Significant insider selling over the past 3 months (₹28m sold). Reported Earnings • Feb 06
Third quarter 2024 earnings released: EPS: ₹0.65 (vs ₹5.00 loss in 3Q 2023) Third quarter 2024 results: EPS: ₹0.65 (up from ₹5.00 loss in 3Q 2023). Revenue: ₹790.7m (up 14% from 3Q 2023). Net income: ₹40.7m (up ₹73.3m from 3Q 2023). Profit margin: 5.2% (up from net loss in 3Q 2023). The move to profitability was driven by higher revenue. Ankündigung • Jan 27
Kamdhenu Ventures Limited to Report Nine Months, 2024 Results on Feb 03, 2024 Kamdhenu Ventures Limited announced that they will report nine months, 2024 results on Feb 03, 2024 New Risk • Jan 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹171m free cash flow). Earnings have declined by 52% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change). Ankündigung • Oct 31
Kamdhenu Ventures Limited to Report Q2, 2024 Results on Nov 07, 2023 Kamdhenu Ventures Limited announced that they will report Q2, 2024 results on Nov 07, 2023 Ankündigung • May 13
Kamdhenu Ventures Limited to Report Q4, 2023 Results on May 18, 2023 Kamdhenu Ventures Limited announced that they will report Q4, 2023 results on May 18, 2023 
